Revolution Medicines (RVMD) Other Gross PP&E Adjustments (2019 - 2025)
Revolution Medicines (RVMD) has 7 years of Other Gross PP&E Adjustments data on record, last reported at -$103.8 million in Q4 2025.
- For Q4 2025, Other Gross PP&E Adjustments fell 13.31% year-over-year to -$103.8 million; the TTM value through Dec 2025 reached -$103.8 million, down 13.31%, while the annual FY2025 figure was -$103.8 million, 13.31% down from the prior year.
- Other Gross PP&E Adjustments reached -$103.8 million in Q4 2025 per RVMD's latest filing, down from -$74.6 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $8.7 million in Q1 2023 and bottomed at -$103.8 million in Q4 2025.
- Average Other Gross PP&E Adjustments over 5 years is -$36.5 million, with a median of -$29.8 million recorded in 2022.
- Peak YoY movement for Other Gross PP&E Adjustments: soared 124.99% in 2023, then crashed 496.21% in 2024.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at -$37.9 million in 2021, then rose by 23.46% to -$29.0 million in 2022, then crashed by 60.26% to -$46.5 million in 2023, then tumbled by 97.23% to -$91.6 million in 2024, then dropped by 13.31% to -$103.8 million in 2025.
- Per Business Quant database, its latest 3 readings for Other Gross PP&E Adjustments were -$103.8 million in Q4 2025, -$74.6 million in Q3 2025, and -$56.3 million in Q2 2025.